Lumos Pharma (LUMO) and Double Point Ventures announced the completion of the previously announced tender offer for Lumos Pharma’s shares at a purchase price of $4.25 per share in cash at ...
Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. Lumos Pharma was founded and is led by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback